Osteoporotic Fracture
Conditions
Interventions
control group:Routinely receive anti-osteoporosis drug treatment and follow-up, and inform patients to take medication and review through in-hospital education and education at discharge.
Experimental group :Improve awareness and attention, and encourage participation: for those with high risk screening results, inform patients and their families of the results, and emphasize the harms
Experimental group:Medication Behavior Modification: Link patient medication behavior to three meals a day during medication instruction. If the medicine is taken three times a day, the patient should
Experimental group:Reminder of drug purchase and medication: According to the amount of drug purchased by the patient and the medication cycle, the patient will be reminded by phone or WeChat 3-7 days
Sponsors
Affiliated Hospital of Youjiang Medical University for Nationalities
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Age =50 years old; (2) Conform to the diagnosis of osteoporotic fracture; (3) Patients voluntarily participate in the research and can provide written informed consent; (4) patients can receive telephone or WeChat interviews or door-to-door visits or visit the hospital for follow-up.
Exclusion criteria
Exclusion criteria: (1) Patients with severe disorders of bone metabolism (including Cushing's disease, hyperthyroidism, hyperparathyroidism, thyroid cyst or hypothyroidism) and bone tuberculosis caused by bone tumor fractures or pathological fractures; (2) Fractures caused by severe violence; (3) Seriously abnormal liver and kidney function; (4) Participating in other studies that affect the results of this study; (5) The researchers believe that it is not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| medication adherence; | — |
Countries
China
Contacts
Public ContactLinXiaozhen
Affiliated Hospital of Youjiang Medical University for Nationalities
Outcome results
None listed